Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease

Fig. 2

Draft ESA Decision Aid. The draft ESA decision aid contains 6 sections organized to be delivered to patients from right to left, then top to bottom. The “Men” and “Women” bars in Sections 1 and 2 represent the hemoglobin levels of individuals without kidney disease, while the “too high” and “too low” bars represent the high and low ranges of hemoglobin levels for individuals with kidney disease, respectively. Section 3 includes information to educate patients about the impact of anemia on patient health and wellness. Section 4 presents the potential health risks of using ESAs to manage anemia, while Section 5 presents the potential benefits. Section 6 contains checkboxes to assist patients with planning their future ESA use

Back to article page